A Middle Ground for Accelerated Drug Approval—Lessons From Aducanumab
Author:
Affiliation:
1. Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2784584/jama_emanuel_2021_vp_210107_1633975988.26411.pdf
Reference10 articles.
1. Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study.;Vitry;J Pharm Policy Pract,2015
2. The Oncologic Drugs Advisory Committee votes of April 2021: implications for the fate of accelerated approval.;Powell;JAMA Oncol,2021
3. The amyloid hypothesis on trial.;Makin;Nature,2018
4. Strength of validation for surrogate end points used in the US Food and Drug Administration’s approval of oncology drugs.;Kim;Mayo Clin Proc,2016
5. FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway.;Mahase;BMJ,2021
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Can requests for real-world evidence by the French HTA body be planned? An exhaustive retrospective case–control study of medicinal products appraisals from 2016 to 2021;International Journal of Technology Assessment in Health Care;2024
2. Design and Rationale for a Real-World Observational Cohort of Patients Living with Progressive Neurological Disease and their care partners: TARGET-NEURO Study;2023-05-24
3. “A Process‐Based Approach to Conflicts of Interest”;Pediatric Pulmonology;2023-03-29
4. Drug trial for Alzheimer’s disease is a game changer;Nature;2023-02-13
5. High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects;Revue Neurologique;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3